Related Experiment Video
Updated: May 12, 2026

Mouse Genome Engineering Using Designer Nucleases
Published on: April 2, 2014
PTEN plasticity: how the taming of a lethal gene can go too far
1Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA.
Abstract:
PTEN loss drives many cancers and recent genetic studies reveal that often PTEN is antagonised at the protein level without alteration of DNA or RNA expression. This scenario can already cause malignancy, because PTEN is haploinsufficient. We here review normally occurring mechanisms of PTEN protein regulation and discuss three processes where PTEN plasticity is needed: ischaemia, development, and wound healing. These situations demand transient PTEN suppression, whereas cancer exploits them for continuous proliferation and survival advantages. Therefore, increased understanding of PTEN plasticity may help us better interpret tumour development and ultimately lead to drug targets for PTEN supporting cancer therapy.
Insights
Loss of PTEN protein, not DNA or RNA, drives cancer by exploiting natural regulatory mechanisms. Understanding PTEN plasticity offers new therapeutic targets for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Phosphatase and tensin homolog (PTEN) loss is a key driver in many cancers.
- PTEN antagonism at the protein level, without DNA or RNA changes, can cause malignancy due to PTEN haploinsufficiency.
- Cancer cells exploit natural PTEN regulatory mechanisms for continuous proliferation.
Purpose of the Study:
- To review normal PTEN protein regulation mechanisms.
- To discuss the role of PTEN plasticity in physiological processes like ischemia, development, and wound healing.
- To explore how understanding PTEN plasticity can inform cancer therapy.
Main Methods:
- Literature review of PTEN protein regulation.
- Analysis of PTEN's role in physiological processes.
- Discussion of therapeutic implications for cancer.
Main Results:
- PTEN protein levels are tightly regulated through various mechanisms.
- Physiological states such as ischemia, development, and wound healing require transient PTEN suppression.
- Cancer cells leverage these transient suppression mechanisms for sustained growth and survival.
Conclusions:
- PTEN plasticity is crucial for normal physiological functions.
- Dysregulation of PTEN plasticity contributes to cancer development.
- Targeting PTEN regulation offers potential avenues for novel cancer therapies.
Related Concept Videos
In-vitro Mutagenesis
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Limits to Natural Selection
What is Genetic Engineering?
Transduction
CRISPR

